Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guanlin Dai

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|October 16, 2025
Case Report: Functional validation of a rare variant <i>BRCA1 c.5193 + 2dupT</i> in a family with cancer historyGuanlin Dai, Ping Wang, Danqing Wang
Frontiers in Oncology|September 5, 2025
Pembrolizumab combined with lenvatinib and metronomic cyclophosphamide in platinum-resistant ovarian cancer: a case report of durable clinical responseGuanlin Dai, Furong Tang, Ping Wang, et al.
Medicine|December 23, 2022
Uterine inflammatory myofibroblastic tumor presented as abnormal uterine bleeding: Two cases report and literature reviewFurong Tang, Guanlin Dai, Xing Huang, et al.
Biochemical Pharmacology|March 9, 2026
Lycorine suppresses cell growth and attenuates stemness through PI3K/AKT pathway in ovarian cancerYaoyao Tan, Liping Xia, Guanlin Dai, et al.
Cancer Medicine|June 12, 2026
Predicting Post-Radiotherapy Epigenetic Age Acceleration From Pre-Treatment Data Using a Machine Learning Framework in Head and Neck Cancer PatientsRunze Yan, Guanlin Dai, Yufen Lin, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|October 16, 2025
Case Report: Functional validation of a rare variant <i>BRCA1 c.5193 + 2dupT</i> in a family with cancer historyGuanlin Dai, Ping Wang, Danqing Wang
Frontiers in Oncology|September 5, 2025
Pembrolizumab combined with lenvatinib and metronomic cyclophosphamide in platinum-resistant ovarian cancer: a case report of durable clinical responseGuanlin Dai, Furong Tang, Ping Wang, et al.
Medicine|December 23, 2022
Uterine inflammatory myofibroblastic tumor presented as abnormal uterine bleeding: Two cases report and literature reviewFurong Tang, Guanlin Dai, Xing Huang, et al.
Biochemical Pharmacology|March 9, 2026
Lycorine suppresses cell growth and attenuates stemness through PI3K/AKT pathway in ovarian cancerYaoyao Tan, Liping Xia, Guanlin Dai, et al.
Cancer Medicine|June 12, 2026
Predicting Post-Radiotherapy Epigenetic Age Acceleration From Pre-Treatment Data Using a Machine Learning Framework in Head and Neck Cancer PatientsRunze Yan, Guanlin Dai, Yufen Lin, et al.
Pageof 1